GEDBX Performance — GMO Emerging Markets Select Equity Fund, Class I
Data updated: 2023-10-27
GEDBX returned +3.34% over one year to Aug 2023. Over one year the fund trailed its Money Market category average: $100 grew to $103, against $104 for the category. Volatility over the past 12 months was 23.67% a year. In the 12 months to Aug 2023 the fund lost a net $91.8M, and assets reached $67.20M.
GEDBX Growth of $100
What $100 invested in GMO Emerging Markets Select Equity Fund grew to, compounded from monthly returns reported on SEC Form N-PORT, against the Money Market category average over the same months.
| Period | GEDBX | Category average |
|---|---|---|
| 1 year (Sep 2022 – Aug 2023) | $103 | $104 |
| Since data start (Jan 2021 – Aug 2023) | $71 | $99 |
GEDBX Trailing Returns
Total returns to Aug 2023, from SEC N-PORT.
| Period | Total return |
|---|---|
| 1 year | +3.34% |
| 3 years (annualised) | −11.91% |
GEDBX Annual Returns
Calendar-year total returns of GMO Emerging Markets Select Equity Fund, compounded from monthly SEC N-PORT returns. Partial years show the months covered.
| Year | Total return |
|---|---|
| 2023 (Jan–Aug) | +7.37% |
| 2022 | −24.66% |
| 2021 | −11.85% |
GEDBX Monthly Returns
Monthly total returns as reported on SEC Form N-PORT.
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023 | +9.6% | −5.1% | +3.5% | −2.1% | −1.0% | +3.7% | +4.1% | −4.7% | — | — | — | — |
| 2022 | −0.7% | −5.9% | −3.4% | −5.2% | −0.4% | −6.2% | −0.9% | −1.1% | −9.3% | −4.5% | +14.6% | −3.0% |
| 2021 | −4.4% | +0.2% | −2.5% | +1.3% | +1.6% | +0.9% | −5.7% | +0.7% | −4.0% | +1.9% | −4.7% | +2.6% |
GEDBX Risk
Risk measures from monthly returns over Sep 2022 – Aug 2023.
- 1-year volatility (annualised): 23.67%
- Best month: +14.57% (Nov 2022)
- Worst month: −9.34% (Sep 2022)
GEDBX Fund Flows
Monthly money in and out of GMO Emerging Markets Select Equity Fund, from SEC Form N-PORT.
- 12-month net flow: −$91.8M
- 12-month gross sales (incl. reinvestments): $21.4M
- Sales ÷ redemptions: 0.19×
| Month | Sales | Redemptions | Net flow |
|---|---|---|---|
| Aug 2023 | $50K | $2.5M | −$2.5M |
| Jul 2023 | $255K | $61K | $194K |
| Jun 2023 | $110K | $0 | $110K |
| May 2023 | $18.1M | $0 | $18.1M |
| Apr 2023 | $14K | $52.7M | −$52.7M |
| Mar 2023 | $290K | $26.6M | −$26.3M |
| Feb 2023 | $100K | $1.7M | −$1.6M |
| Jan 2023 | $20K | $194K | −$174K |
| Dec 2022 | $2.4M | $22.9M | −$20.5M |
| Nov 2022 | $0 | $519K | −$519K |
| Oct 2022 | $52K | $5.9M | −$5.9M |
| Sep 2022 | $0 | $133K | −$133K |
GEDBX Assets Under Management
Net assets of GMO Emerging Markets Select Equity Fund by report date, from SEC N-PORT filings.
| Report date | Net assets |
|---|---|
| 2023-08-31 | $67.20M |
| 2023-05-31 | $67.57M |
| 2023-02-28 | $126.19M |
| 2022-11-30 | $150.53M |
| 2022-08-31 | $158.94M |
| 2022-05-31 | $687.04M |
| 2022-02-28 | $761.47M |
| 2021-11-30 | $771.16M |
| 2021-08-31 | $931.62M |
| 2021-05-31 | $1.03B |
| 2021-02-28 | $1.04B |
| 2020-11-30 | $1.01B |
For information only. Not investment advice: figures are as reported in SEC filings and may contain errors or be out of date. Past performance does not guarantee future results.